4145 related articles for article (PubMed ID: 7139650)
1. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
Creagan ET; Schutt AJ; Ahmann DL; Green SJ
Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of aziridinylbenzoquinone (NSC 182986).
Bedikian AY; Bodey GP; Burgess MA; Freireich EJ
Cancer Clin Trials; 1981; 4(4):459-63. PubMed ID: 7318128
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.
Forastiere AA; Crain SM; Callahan K; Van Echo D; Mattox D; Thant M; Von Hoff DD; Wiernik PH
Cancer Treat Rep; 1982 Dec; 66(12):2097-8. PubMed ID: 6892491
[No Abstract] [Full Text] [Related]
4. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
[TBL] [Abstract][Full Text] [Related]
5. Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).
Carey RW; Comis RL; Anbar D; Kennedy BJ; Capizzi RL; Shulman P; Booth BW; Green M; Raich PC
Cancer Treat Rep; 1983 Jan; 67(1):95-6. PubMed ID: 6616498
[No Abstract] [Full Text] [Related]
6. Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
Griffin JP; Newman RA; McCormack JJ; Krakoff IH
Cancer Treat Rep; 1982 Jun; 66(6):1321-5. PubMed ID: 7083235
[TBL] [Abstract][Full Text] [Related]
7. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
[No Abstract] [Full Text] [Related]
8. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
Tan CT; Hancock CH; Mondora A; Hoffman NW
Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.
McLaughlin P; Cabanillas F; Bedikian AY; Bodey GP
Cancer Treat Rep; 1983 May; 67(5):507-8. PubMed ID: 6850666
[No Abstract] [Full Text] [Related]
10. Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).
Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD
Am J Clin Oncol; 1983 Oct; 6(5):577-8. PubMed ID: 6613923
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of diaziquone.
Frytak S; Eagan RT; Ames MM; Creagan ET; Nichols WC
Cancer Treat Rep; 1984; 68(7-8):975-8. PubMed ID: 6744349
[TBL] [Abstract][Full Text] [Related]
13. AZQ therapy in patients with disseminated malignant melanoma.
Yap BS; Bedikian AY; Burgess MA; Bodey GP
Am J Clin Oncol; 1982 Dec; 5(6):623-5. PubMed ID: 7165003
[TBL] [Abstract][Full Text] [Related]
14. Phase I evaluation and pharmacokinetics of aziridinylbenzoquinone using a weekly intravenous schedule.
Schilcher RB; Young JD; Leichman LP; Haas CD; Baker LH
Cancer Res; 1983 Aug; 43(8):3907-11. PubMed ID: 6683127
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical evaluation of AZQ in metastatic breast cancer.
Yap HY; Bedikian AY; Schell FC; Blumenschein GR; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):31-3. PubMed ID: 6837505
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of aziridinylbenzoquinone in refractory lymphoma.
Case DC; Hayes DM
Cancer Treat Rep; 1983 Nov; 67(11):993-6. PubMed ID: 6357437
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung.
Fuks JZ; Aisner J; Van Echo DA; Levitt M; Ihde DC; Carney D; Wiernik PH
Am J Clin Oncol; 1983 Apr; 6(2):171-3. PubMed ID: 6299094
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
Schilsky RL; Kelley JA; Ihde DC; Howser DM; Cordes RS; Young RC
Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
Høst H; Joss R; Pinedo H; Bruntsch U; Cavalli F; Renard G; van Glabbeke M; Rozencweig M
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):295-8. PubMed ID: 6681775
[TBL] [Abstract][Full Text] [Related]
20. Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia.
Kamen BA; Holcenberg JS; Siegel SE
Cancer Treat Rep; 1982 Dec; 66(12):2105-6. PubMed ID: 6958367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
